Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.inogen.com

Address:

859 Ward Drive, Goleta, United States

RunnerSignals Nov. 15 at 4:53 PM

$COIN $EVGO $INGN $KAI $LW oversold and ready for a rebound or more pain? The charts are talking, are you listening? https://stocksrunner.com/news/2025-11-15-daily-market-pulse-advanced-technical-analysis

0 · Reply

SuperGreenToday Nov. 13 at 9:50 PM

$INGN Share Price: $6.89 Contract Selected: Jun 18, 2026 $7.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 50% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Nov. 6 at 7:59 PM

$INGN's loss narrows but shares plunge 8.3% — what's going on? 🤔 📉 Missed revenue estimate despite 4% YoY growth ⚠️ Decline in domestic direct-to-consumer and rental revenues 💡 New product launches show promise, but challenges remain Understand the risks before investing in INGN 👉 https://www.zacks.com/stock/news/2787146/inogen-stock-dips-despite-q3-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2787146-body-19956&ADID=SYND_STOCKTWITS_TWEET_2_2787146_BODY_19956

0 · Reply

ZacksResearch Nov. 6 at 6:59 PM

$INGN beats Q3 earnings — but investors aren’t buying it. A narrower loss and stronger B2B demand couldn’t offset softness in consumer and rental sales, pushing the stock lower. Full results breakdown here 👉 https://www.zacks.com/stock/news/2787146/inogen-stock-dips-despite-q3-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2787146-teaser-19945&ADID=SYND_STOCKTWITS_TWEET_2_2787146_TEASER_19945

0 · Reply

kaefer Nov. 5 at 12:49 PM

$INGN reports earnings https://www.businesswire.com/news/home/20251105832834/en

0 · Reply

BillionerOfKing Nov. 4 at 4:18 PM

$INGN Current Stock Price: $8.14 Contracts to trade: $10 INGN Nov 21 2025 Call Entry: $0.36 Exit: $0.48 ROI: 34% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Pnmoltke Oct. 15 at 2:28 PM

$INGN $INGN have approx. 700 employees today so its basically 5-6% of the workforce they are suddenly having as new job hires (40 in total). Half of it alone here in October. A reason behind this relatively many hires could be that growth are finally picking up for Inogen. I look forward to their Q3 on November 5th.

0 · Reply

Pnmoltke Oct. 13 at 12:56 PM

$INGN Number of jobs adds increasing rapidly! 6-9 month ago there was only 10-12 jobs adds on Inogens site. Now there is almost 40 and half of it are new ones from October 2025. Is growth picking up with the launch of Voxi 5 i july amonst others?

0 · Reply

assisi Oct. 7 at 5:00 PM

@sogenerous apologies for putting another non AI or tech name on the radar but $INGN potentially worth a look

0 · Reply

quantMoth Oct. 5 at 7:49 AM

$INGN Genomic medicine focus. Testing breakout level. Volume confirmation needed. Relative strength improving.

0 · Reply

Slow Progress At Inogen

Nov 5, 2025, 5:01 PM EST - 10 days ago

Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:30 AM EST - 11 days ago

Inogen Announces Third Quarter 2025 Financial Results

Oct 15, 2025, 8:30 AM EDT - 4 weeks ago

Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025

Sep 25, 2025, 4:05 PM EDT - 7 weeks ago

Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

Aug 8, 2025, 6:18 PM EDT - 3 months ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 3 months ago

Inogen Announces Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 4 months ago

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 23, 2025, 8:30 AM EDT - 5 months ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

May 22, 2025, 1:38 PM EDT - 6 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 6 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 8 months ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 9 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 9 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 9 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 9 months ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 10 months ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 10 months ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 10 months ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 10 months ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 11 months ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 1 year ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 1 year ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 1 year ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 1 year ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 2 years ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 2 years ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 7, 2023, 11:08 PM EST - 2 years ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 2 years ago

Inogen Announces Third Quarter 2023 Financial Results

Oct 10, 2023, 4:00 PM EDT - 2 years ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist

Sep 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Announces CFO Transition Plan

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

RunnerSignals Nov. 15 at 4:53 PM

0 · Reply

SuperGreenToday Nov. 13 at 9:50 PM

0 · Reply

ZacksResearch Nov. 6 at 7:59 PM

0 · Reply

ZacksResearch Nov. 6 at 6:59 PM

0 · Reply

kaefer Nov. 5 at 12:49 PM

$INGN reports earnings https://www.businesswire.com/news/home/20251105832834/en

0 · Reply

BillionerOfKing Nov. 4 at 4:18 PM

0 · Reply

Pnmoltke Oct. 15 at 2:28 PM

0 · Reply

Pnmoltke Oct. 13 at 12:56 PM

0 · Reply

assisi Oct. 7 at 5:00 PM

@sogenerous apologies for putting another non AI or tech name on the radar but $INGN potentially worth a look

0 · Reply

quantMoth Oct. 5 at 7:49 AM

$INGN Genomic medicine focus. Testing breakout level. Volume confirmation needed. Relative strength improving.

0 · Reply

ZacksResearch Sep. 23 at 12:51 PM

$INGN poised for growth in the POC space! 📈 🚀 Anticipating 37.5% earnings growth for 2025, driven by a strong product lineup, while strategic collaborations enhance market presence. 💰 Attractive valuation with a P/S ratio of 0.7X vs. the industry’s 2.7X. See why INGN could outperform 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-body-13632&ADID=SYND_STOCKTWITS_TWEET_2_2755480_BODY_13632

0 · Reply

ZacksResearch Sep. 23 at 11:51 AM

$INGN — time to load up? 🚀 Expanding product lineup + strong POC prospects = a bullish setup that’s hard to ignore. Discover why this stock could deserve a spot in your portfolio 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-teaser-13631&ADID=SYND_STOCKTWITS_TWEET_2_2755480_TEASER_13631

0 · Reply

macroaxis Sep. 21 at 7:40 AM

$INGN – Inogen Max Pain Price Drops to -1.0, Signaling Potential Bullish Momentum https://www.macroaxis.com/stock-options/INGN/Inogen-Inc?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

EquityNest Sep. 15 at 10:20 AM

$INGN Growth depends on demand recovery and margin discipline

0 · Reply

NVDAMillionaire Sep. 4 at 5:33 PM

$INGN Great piece that accurately captures INGN's current position. So if you want to refresh your understanding of INGN or learn about INGN for the first time, this is essential reading. https://beyondspx.com/quote/INGN/inogen-s-resurgence-from-portable-niche-to-respiratory-powerhouse-nasdaq-ingn#analysis

1 · Reply

Rebexxinfx Sep. 2 at 6:05 PM

$INGN woohooooo

0 · Reply

Pnmoltke Aug. 29 at 9:06 AM

$INGN I have been follwing the stock for a while and are in again at around USD 6,8. Remember this stock was almost USD 300 back in 2016 (no split😅). New management have been working on a turnaround plan that now starts to work. At the CC in august 2025 they have some comments about dobble digit revenue growth in Q4 25 and beyond. In their international business and business to business US they are growing double digit. Its their direct to consumer business that have had negative growth for 10-12 quarters. That segment now starts to stabilize according to the CC. Also recently they have introduced Voxi 5 a stationary oxygen inhalator. This segment (SOC) they have not been in before as they have focused on The POC market ( portable). The SOC market is much bigger. Their balancesheet are very healthy with a cash position of aprox. USD 124 mio. (Market cap USD 215 m). Inogen can easily run 3-5x if they start to show decent growth which I believe will start around Q4 25.

0 · Reply

FuturesFinesse Aug. 27 at 9:49 AM

$INGN momentum slowing down, needs strength to push higher.

0 · Reply

Rebexxinfx Aug. 26 at 5:00 PM

$INGN why am I the only person here 🫠let’s squeeze this low floater

0 · Reply

Rebexxinfx Aug. 14 at 7:19 PM

$RILY just want to draw your attention to this guy that BRiley just initiated coverage on with a buy rating : $INGN. Calls are ridiculous cheap, moderately low float and she’s heating up

0 · Reply

Rebexxinfx Aug. 14 at 7:16 PM

$INGN $10 calls Sept19 .05 don’t mind if I dooooooooooooooooooo

0 · Reply

Rebexxinfx Aug. 14 at 5:53 PM

$INGN golden cross incoming? 👀

0 · Reply

Market Cap	187.32M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.69%
Debt to Equity Ratio	0.00

Volume	147,600
Avg Vol	185,430
Day's Range	N/A - N/A
Shares Out	27.15M
Stochastic %K	8%
Beta	1.83
Analysts	Sell
Price Target	$13.00